Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1200-1202

  Deharo, Pierre ^a,b   Pankert, Mathieu ^a,b   Bonnet, Guillaume ^a,b   Quilici, Jacques ^a,b   Bassez, Clemence ^a,b   Morange, Pierre ^a,b   Alessi, Marie Christine ^a,b   Bonnet, Jean Louis ^a,b   Cuisset, Thomas ^a,b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Acute coronary syndrome; Body mass index; Platelet reactivity; Platelets; Prasugrel; Ticagrelor

Indexed keywords

ADENOSINE; PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; DRUG EFFECTS; FEMALE; HUMAN; MALE; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ACUTE CORONARY SYNDROME; ADENOSINE; BLOOD PLATELETS; BODY MASS INDEX; FEMALE; HUMANS; MALE; PIPERAZINES; PLATELET AGGREGATION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES;

EID: 84908215613     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.228     Document Type: Article

References (10)

1. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
2. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 36 2009 1045 1057
3. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), P.G. Steg, and S.K. James ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
4. G.W. Stone, B. Witzenbichler, and G. Weisz Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 9892 2013 614 623
5. D. Sibbing, O. von Beckerath, A. Schömig, A. Kastrati, and N. von Beckerath Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention Am J Cardiol 100 2007 203 205
6. M. Pankert, J. Quilici, and A.D. Loundou Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting Am J Cardiol 113 2014 54 59
7. P. Deharo, C. Bassez, and G. Bonnet Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison Int J Cardiol 170 2013 e21 e22
8. T. Cuisset, M. Loosveld, and P.E. Morange CYP2C19∗2 and∗17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome JACC Cardiovasc Interv 5 2012 1280 1287
9. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
10. C. Bassez, P. Deharo, and G. Bonnet Effectiveness of switching 'low responders' from prasugrel to ticagrelor after acute coronary syndrome 2014 10.1016/j.ijcard.2014.07.239